Hypothyroidism: Causes, Symptoms, and Diagnostic Tests

The thyroid gland constitutes a vital component of the endocrine system, situated in the anteroinferior region of the neck, immediately beneath the thyroid cartilage of the larynx. This relatively small yet profoundly influential organ, weighing approximately thirty grams, comprises two symmetrical lobes—left and right—connected by a narrow band of tissue known as the isthmus. As a cornerstone of hormonal regulation, the thyroid synthesizes and releases three critical hormones into the bloodstream: triiodothyronine (abbreviated as T3), thyroxine (T4), and calcitonin, each of which plays an irreplaceable role in maintaining systemic homeostasis. Thyroid hormones govern the metabolic rate, exert influence over both the peripheral and central nervous systems, modulate cardiovascular activity, and contribute significantly to electrolyte balance—particularly calcium and phosphate metabolism. Disruptions in the secretion or function of these substances can precipitate severe physiological dysfunctions; hence, the routine monitoring of thyroid hormone levels and the early detection of potential abnormalities represent a cornerstone of preventive healthcare.

Hypothyroidism, clinically referred to as an underactive thyroid, constitutes a metabolic disorder marked by deficient circulating levels of thyroid hormones—thyroxine (T4) and triiodothyronine (T3)—or impaired hormonal activity at the target tissue level. The pathogenesis of this endocrine dysfunction is multifactorial, encompassing both primary and secondary causative pathways. Predominant etiologies contributing to hormonal insufficiency include: • autoimmune-mediated processes (e.g., Hashimoto’s thyroiditis, the leading cause in iodine-sufficient regions), • mechanical trauma or surgical interventions involving the thyroid gland (including total or partial thyroidectomy), • intrinsic thyroid pathologies of inflammatory, neoplastic, or degenerative origin, • sustained dietary iodine deficiency (particularly prevalent in endemic areas), • iatrogenic sequelae of hyperthyroidism management (e.g., post-radioiodine ablation or antithyroid drug therapy), • congenital defects in hormone synthesis (e.g., thyroid dysgenesis or agenesis), • exposure to ionizing radiation in the cervical region (associated with radiotherapy for head and neck malignancies), • adverse pharmacological effects of specific medications (e.g., amiodarone, lithium, alpha-interferon).

Hypothyroidism can manifest through a wide array of symptoms, some of which are readily apparent, while others remain concealed or may be mistaken for unrelated conditions. Due to this broad and varied presentation, patients are frequently subjected to multiple diagnostic evaluations and treatments for different ailments before the underlying thyroid dysfunction is identified. Among the most common—though by no means exhaustive—symptoms of this hormonal disorder are: visible swelling in the neck region (known as a goiter), a sensation of pressure or discomfort in the throat, impaired concentration, deterioration in both short- and long-term memory, difficulty swallowing, excessive drowsiness even after adequate rest, erectile dysfunction in men, reduced sexual desire, fluid retention leading to edema, irregular menstrual cycles in women, joint and muscle pain, symptoms resembling coronary artery disease, hoarseness or alterations in voice pitch, shortness of breath during physical exertion, shallow and rapid breathing, persistent fatigue, weight gain despite unchanged dietary habits, a constant sensation of cold, chronic constipation, brittle nails prone to breakage, excessive hair loss, dermatological issues such as dryness, roughness, or pallor, and depressive episodes of varying severity. Given the extensive range of symptoms, hypothyroidism can be challenging to diagnose, potentially delaying the initiation of appropriate treatment. If left untreated, this condition may progress to severe complications, including cardiovascular diseases, infertility, cardiac arrhythmias, and, in extreme cases, hypometabolic coma—a life-threatening state that can lead to systemic failure and death.

To accurately diagnose hypothyroidism, a thorough assessment of the hormonal profile is indispensable, encompassing the measurement of key indicators such as triiodothyronine (abbreviated as T3), thyroxine (T4), and thyroid-stimulating hormone (TSH, also referred to as thyrotropin). The initial step in the diagnostic workflow should involve the quantification of serum TSH levels. An elevated concentration of this hormone typically signifies primary hypothyroidism, which is generally accompanied by a concurrent reduction in T3 values. Conversely, in cases of secondary hypothyroidism, diminished levels of TSH, T3, and T4 are observed. Meanwhile, the subclinical (or latent) form of hypothyroidism is characterized by elevated TSH alongside normal T3 and T4 concentrations. To ascertain the precise etiology of the dysfunction, an ultrasound examination of the thyroid gland is additionally recommended. In advanced stages where symptomatology is pronounced, further diagnostic measures such as abdominal ultrasonography and chest X-ray may be warranted to detect potential abnormalities, including fluid accumulation within body cavities.

The management of hypothyroidism, or thyroid hormone deficiency, is primarily centered on the consistent replenishment of hormonal deficits through the administration of synthetic levothyroxine sodium. An absolute prerequisite before initiating therapy is an endocrinological consultation, during which an individualized starting dose will be determined based on the patient’s age, body weight, and any coexisting medical conditions. Unauthorized adjustments to the treatment regimen carry significant health risks—any dosage modifications must be approved by the attending physician. The optimal time for medication intake is in the morning, on an empty stomach, with a minimum 30- to 60-minute interval before the first meal to ensure maximal bioavailability of the active ingredient. It is advisable to avoid taking the medication with juices, coffee, or milk, as these beverages may interfere with hormone absorption. In the initial phase of treatment, frequent laboratory monitoring is essential—thyroid-stimulating hormone (TSH) levels should be measured every 6 to 12 weeks until metabolic stabilization is achieved. Once euthyroidism is restored, the frequency of testing can be reduced to biannual assessments. It is crucial to emphasize that hypothyroidism typically necessitates lifelong hormonal supplementation and ongoing clinical surveillance, as spontaneous remissions are exceedingly rare and generally limited to patients with transient forms of the disorder.